Sorry, your browser is incompatible.

Our site is best viewed in Chrome, Firefox, and IE11. Please upgrade your browser and visit again soon. Thank you!

DLC In the News

DLC Board Member George Huntley was quoted in two recent news stories regarding the increasingly high cost of insulin for patients with diabetes. In stories published online by INDYStar on September 8, 2017  and USA Today on September 13, 2017, the DLC and other diabetes advocacy organizations call on Lilly Diabetes and other manufacturers of insulin to be transparent about how much it costs to make insulin and how much they earn from sales of the drug, and further to be proactive in efforts to make the life-saving drug more affordable for patients.

Read the INDYStar article here.

Read the USA Today article here.

 

Get Involved

Become an official sponsor of the DLC.